贝伐单抗联合吉西他滨和厄洛替尼在转移性胰腺癌的Ⅲ期临床研究

    Phase Ⅲ Trial of Bevacizumab in Combination with Gemcitabine and Erlotinib in Patients with Metastatic Pancreatic Cancer

    /

    返回文章
    返回